Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.
Saved in:
| Title: | Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway. |
|---|---|
| Authors: | Li L; 1] School of Ocean, Shandong University, Weihai 264209, China [2] School of Pharmaceutical Sciences, Shandong University, Ji-nan 250012, China., Zheng BB; School of Ocean, Shandong University, Weihai 264209, China., Ma LS; School of Ocean, Shandong University, Weihai 264209, China., Sun X; School of Ocean, Shandong University, Weihai 264209, China., Chang JJ; School of Ocean, Shandong University, Weihai 264209, China., Xie WD; School of Ocean, Shandong University, Weihai 264209, China., Li X; 1] School of Ocean, Shandong University, Weihai 264209, China [2] School of Pharmaceutical Sciences, Shandong University, Ji-nan 250012, China. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2014 Oct; Vol. 35 (10), pp. 1311-22. Date of Electronic Publication: 2014 Sep 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
